KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts

Biochemical and Biophysical Research Communications

Volumn 338, Issue 4, 2005, Pages 1845-1852

  Ohshimo, Shinichiro ^a   Yokoyama, Akihito ^a   Hattori, Noboru ^a   Ishikawa, Nobuhisa ^a   Hirasawa, Yutaka ^b   Kohno, Nobuoki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Kitaishikai Uchiyama Hospital   (Japan)

Author keywords

Apoptosis; Idiopathic pulmonary fibrosis; Interstitial lung disease; Therapeutic agent

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GLYCOPROTEIN; MONOCLONAL ANTIBODY; MUCIN 1; PLATELET DERIVED GROWTH FACTOR; PROTEIN KL 6; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, NEOPLASM; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; FIBROBLASTS; GLYCOPROTEINS; HUMANS; IN SITU NICK-END LABELING; LUNG; LUNG DISEASES, INTERSTITIAL; MUCINS;

ANIMALIA;

EID: 27844571322     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.10.144     Document Type: Article

References (35)

1. A.L. Katzenstein, and J.L. Myers Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification Am. J. Respir. Crit. Care Med. 157 1998 1301 1315
2. M. Selman, T.E. King, and A. Pardo Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy Ann. Intern. Med. 134 2001 136 151
3. N. Kohno, M. Akiyama, S. Kyoizumi, M. Hakoda, K. Kobuke, and M. Yamakido Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma Jpn. J. Clin. Oncol. 18 1988 203 216
4. N. Kohno, Y. Inoue, H. Hamada, S. Fujioka, S. Fujino, A. Yokoyama, K. Hiwada, N. Ueda, and M. Akiyama Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9 Int. J. Cancer Suppl. 8 1994 81 83
5. N. Kohno, S. Kyoizumi, Y. Awaya, H. Fukuhara, M. Yamakido, and M. Akiyama New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6 Chest 96 1989 68 73
6. N. Kohno, A. Yokoyama, Y. Hirasawa, K. Kondo, S. Fujino, M. Abe, and K. Hiwada Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia Respir. Med. 91 1997 558 561
7. H. Ohnishi, A. Yokoyama, K. Kondo, H. Hamada, M. Abe, K. Nishimura, K. Hiwada, and N. Kohno Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases Am. J. Respir. Crit. Care Med. 165 2002 378 381
8. N. Kohno, Y. Awaya, T. Oyama, M. Yamakido, M. Akiyama, Y. Inoue, A. Yokoyama, H. Hamada, S. Fujioka, and K. Hiwada KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease Am. Rev. Respir. Dis. 148 1993 637 642
9. A. Yokoyama, N. Kohno, H. Hamada, M. Sakatani, E. Ueda, K. Kondo, Y. Hirasawa, and K. Hiwada Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis Am. J. Respir. Crit. Care Med. 158 1998 1680 1684
10. N. Kohno, H. Hamada, S. Fujioka, K. Hiwada, M. Yamakido, and M. Akiyama Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer Chest 102 1992 117 122
11. H. Ohnishi, A. Yokoyama, Y. Yasuhara, A. Watanabe, T. Naka, H. Hamada, M. Abe, K. Nishimura, J. Higaki, J. Ikezoe, and N. Kohno Circulating KL-6 levels in patients with drug induced pneumonitis Thorax 58 2003 872 875
12. R. Janssen, H. Sato, J.C. Grutters, A. Bernard, H. van Velzen-Blad, R.M. du Bois, and J.M. van den Bosch Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis Chest 124 2003 2119 2125
13. T. Takahashi, M. Munakata, I. Suzuki, and Y. Kawakami Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis Am. J. Respir. Crit. Care Med. 158 1998 1294 1298
14. A. Ishizaka, T. Matsuda, K.H. Albertine, H. Koh, S. Tasaka, N. Hasegawa, N. Kohno, T. Kotani, H. Morisaki, J. Takeda, M. Nakamura, X. Fang, T.R. Martin, M.A. Matthay, and S. Hashimoto Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome Am. J. Physiol. Lung Cell. Mol. Physiol. 286 2004 L1088 L1094
15. H. Hamada, N. Kohno, A. Yokoyama, Y. Hirasawa, K. Hiwada, M. Sakatani, and E. Ueda KL-6 as a serologic indicator of Pneumocystis carinii pneumonia in immunocompromised hosts Intern. Med. 37 1998 307 310
16. Y. Hirasawa, N. Kohno, A. Yokoyama, Y. Inoue, M. Abe, and K. Hiwada KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts Am. J. Respir. Cell. Mol. Biol. 17 1997 501 507
17. H. Hamada, N. Kohno, and K. Hiwada A new serum tumor marker, CAM 123-6, highly specific to pulmonary adenocarcinoma Jpn. J. Cancer Res. 85 1994 211 219
18. S.K. Goparaju, P.S. Jolly, K.R. Watterson, M. Bektas, S. Alvarez, S. Sarkar, L. Mel, I. Ishii, J. Chun, S. Milstien, and S. Spiegel The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation Mol. Cell. Biol. 25 2005 4237 4249
19. Y. Aono, Y. Nishioka, M. Inayama, M. Ugai, J. Kishi, H. Uehara, K. Izumi, and S. Sone Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice Am. J. Respir. Crit. Care Med. 171 2005 1279 1285
20. Y. Zhao, and S.L. Young Requirement of transforming growth factor-beta (TGF-beta) type II receptor for TGF-beta-induced proliferation and growth inhibition J. Biol. Chem. 271 1996 2369 2372
21. T.A. Wynn Fibrotic disease and the T(H)1/T(H)2 paradigm Nat. Rev. Immunol. 4 2004 583 594
22. A. Abdollahi, M. Li, G. Ping, C. Plathow, S. Domhan, F. Kiessling, L.B. Lee, G. McMahon, H.J. Grone, K.E. Lipson, and P.E. Huber Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis J. Exp. Med. 201 2005 925 935
23. V.C. Midgley, and L.M. Khachigian Fibroblast growth factor-2 induction of platelet-derived growth factor-C chain transcription in vascular smooth muscle cells is ERK-dependent but not JNK-dependent and mediated by Egr-1 J. Biol. Chem. 279 2004 40289 40295
24. S.H. Wu, X.H. Wu, C. Lu, L. Dong, and Z.Q. Chen Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by CTGF Am. J. Respir. Cell. Mol. Biol. 2005 [Epub ahead of print]
25. M. Selman, and A. Pardo The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis Am. J. Respir. Cell. Mol. Biol. 29 2003 S93 S97
26. J.V. Barbas-Filho, M.A. Ferreira, A. Sesso, R.A. Kairalla, C.R. Carvalho, and V.L. Capelozzi Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP) J. Clin. Pathol. 54 2001 132 138
27. K. Kuwano, H. Miyazaki, N. Hagimoto, M. Kawasaki, M. Fujita, R. Kunitake, Y. Kaneko, and N. Hara The involvement of Fas-Fas ligand pathway in fibrosing lung diseases Am. J. Respir. Cell. Mol. Biol. 20 1999 53 60
28. T. Tanaka, M. Yoshimi, T. Maeyama, N. Hagimoto, K. Kuwano, and N. Hara Resistance to Fas-mediated apoptosis in human lung fibroblast Eur. Respir. J. 20 2002 359 368
29. S. Bai, H. Liu, K.H. Chen, P. Eksarko, H. Perlman, T.L. Moore, and R.M. Pope NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis Arthritis Rheum. 50 2004 3844 3855
30. Z. Li, J. Zhang, D. Chen, and H.B. Shu Casper/c-FLIP is physically and functionally associated with NF-kappaB1 p105 Biochem. Biophys. Res. Commun. 309 2003 980 985
31. M.P. Chong, G.J. Barritt, and M.F. Crouch Insulin potentiates EGFR activation and signaling in fibroblasts Biochem. Biophys. Res. Commun. 322 2004 535 541
32. J.L. Ingram, A.B. Rice, K. Geisenhoffer, D.K. Madtes, and J.C. Bonner IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha FASEB J. 18 2004 1132 1134
33. E.A. Harrington, M.R. Bennett, A. Fanidi, and G.I. Evan c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines EMBO J. 13 1994 3286 3295
34. H. Kazama, and S. Yonehara Oncogenic K-Ras and basic fibroblast growth factor prevent Fas-mediated apoptosis in fibroblasts through activation of mitogen-activated protein kinase J. Cell Biol. 148 2000 557 566
35. H.H. Chen, S. Zhao, and J.G. Song TGF-beta1 suppresses apoptosis via differential regulation of MAP kinases and ceramide production Cell Death Differ. 10 2003 516 527